Design Considerations for Pivotal Clinical Investigations for Medical Devices

FDA Guidance FDA CDRH/CBER 2013-11-01
Home/ Resources/ Design Considerations for Pivotal Clinical…

Summary

Final Guidance
Clinical Evidence

This FDA guidance document provides recommendations and regulatory information for the medical device industry. It was issued by the Center for Devices and Radiological Health (CDRH) in collaboration with the Center for Biologics Evaluation and Research (CBER).

Document Details

  • Issuing Authority: FDA CDRH/CBER
  • Status: Final
  • Topic Area: Clinical Evidence
  • Date: 2013-11-01

Access the Full Document

View on FDA.gov →

Source: U.S. Food and Drug Administration (FDA). This content is provided for informational purposes. Always refer to the official FDA document for the most current version.

Document Details

Document IDFDA-CDRH-DESIGN-CONSIDERATIONS-FOR-PIVOTAL-CLINICAL-INVESTI
TypeFDA Guidance
AuthorityFDA CDRH/CBER
Publication Date2013-11-01

Download Document

Download PDF

Categories

Quick Info

TypeFDA Guidance
Published ByFDA CDRH/CBER
Date2013-11-01

Regulatory Support

Need help understanding this guidance document?

Contact Us
Scroll to Top